SCF ENCYCLOPEDIA ENTRY

SCF-RDOS INDICATION REGISTRY

POSTPARTUM HEART FAILURE

SCF-RDOS Registry Code: SCF-RDOS-PPD-CV-002

ICD Alignment: Postpartum Heart Failure Syndromes

SCF Classification: Postpartum Cardiovascular Disease

SCF Disease Domain: Maternal Cardiocirculatory Failure Disorder

SCF Pathogenesis Tier: Tier IV–VII Systemic Cardiovascular Failure

Clinical Category: Postpartum Cardiac Decompensation Syndrome

SCF Clinical Priority Level: Critical / Life-Threatening

FDA Therapeutic Area: Cardiovascular Disease / Heart Failure

1. DEFINITION

Postpartum Heart Failure (PPHF) is a clinical syndrome characterized by the inability of the maternal cardiovascular system to maintain adequate cardiac output during the postpartum period, resulting in pulmonary congestion, systemic hypoperfusion, and multiorgan dysfunction.

PPHF may arise from:

Peripartum cardiomyopathy
Hypertensive heart disease
Valvular heart disease
Congenital heart disease
Myocarditis
Ischemic heart disease
Arrhythmia-associated cardiomyopathy
Fluid overload syndromes

Within the SCF framework, Postpartum Heart Failure represents:

A multisystem bioenergetic, neurohormonal, vascular, and inflammatory collapse syndrome resulting in failure of maternal circulatory homeostasis during the puerperium.

2. SCF ETIOPATHOGENIC CORE

Primary Disease Drivers

Hemodynamic Overload

Pregnancy-associated:

Plasma volume expansion
Increased preload
Increased cardiac workload

Postpartum:

Autotransfusion from uterine involution
Rapid fluid shifts
Increased venous return

Cardiac Dysfunction

Potential mechanisms:

Ventricular systolic dysfunction
Ventricular diastolic dysfunction
Myocardial inflammation
Ventricular remodeling

Neurohormonal Dysregulation

Activation of:

Renin-Angiotensin-Aldosterone System (RAAS)
Sympathetic nervous system
Vasopressin pathways

Immune Dysregulation

Cytokine activation
Endothelial inflammation
Postpartum inflammatory rebound

Metabolic Dysfunction

ATP depletion
Mitochondrial stress
Oxidative injury

3. SCF FAULT ARCHITECTURE

SCF Fault Node	Functional Failure
ATP Collapse Node	Reduced myocardial energy generation
Mitochondrial Failure Node	Impaired cardiomyocyte function
Neurohormonal Hyperactivation Node	Excess RAAS and sympathetic signaling
Endothelial Dysfunction Node	Vascular instability
ECM Remodeling Node	Structural ventricular changes
Pulmonary Congestion Node	Impaired oxygen exchange
Immune Desynchronization Node	Inflammatory myocardial injury
Multiorgan Hypoperfusion Node	Secondary organ dysfunction

4. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Predisposing variants may involve:

TTN
LMNA
DSP
FLNC
BAG3
MYH7

Result:

Reduced myocardial resilience
Increased susceptibility to cardiac decompensation

Transcriptomics

Upregulated:

TNF-α
IL-6
IL-1β
NF-κB

Downregulated:

Mitochondrial biogenesis pathways
Angiogenic repair pathways

Proteomics

Abnormalities include:

Matrix metalloproteinase activation
Collagen remodeling
Sarcomeric protein dysfunction

Metabolomics

Characteristic findings:

ATP depletion
Reduced fatty acid oxidation
Increased oxidative stress metabolites
Altered lactate metabolism

Epigenomics

Potential contributors:

Inflammatory epigenetic programming
Oxidative stress-mediated transcriptional changes

Interactomics

Affected signaling networks:

VEGF
STAT3
PI3K/AKT
AMPK
RAAS pathways

Connectomics

Autonomic abnormalities:

Sympathetic dominance
Reduced vagal activity
Neurocardiac dysregulation

Biomechanicalomics

Structural dysfunction:

Ventricular dilation
Elevated wall stress
ECM instability
Reduced myocardial compliance

5. SCF PATHOGENESIS FLOW

Stage 1 — Pregnancy Cardiovascular Adaptation

Increased:

Blood volume
Cardiac output
Myocardial workload

↓

Stage 2 — Postpartum Hemodynamic Shift

Rapid:

Fluid redistribution
Venous return increase
Circulatory stress

↓

Stage 3 — Cardiac Vulnerability Exposure

Underlying:

Cardiomyopathy
Hypertension
Structural heart disease

becomes clinically apparent

↓

Stage 4 — Neurohormonal Activation

RAAS activation

↓

Sympathetic activation

↓

Fluid retention

↓

Stage 5 — Ventricular Dysfunction

Reduced contractility

Impaired relaxation

↓

Stage 6 — Congestive Failure

Pulmonary edema

↓

Reduced tissue perfusion

↓

Organ dysfunction

↓

Stage 7 — Critical Decompensation

Cardiogenic shock

↓

Multiorgan failure

↓

Death

6. CLINICAL PRESENTATION

Early Symptoms

Fatigue
Dyspnea on exertion
Exercise intolerance
Orthopnea
Palpitations

Progressive Symptoms

Pulmonary edema
Persistent cough
Paroxysmal nocturnal dyspnea
Peripheral edema
Ascites

Advanced Disease

Cardiogenic shock
Respiratory failure
Renal dysfunction
Ventricular arrhythmias
Sudden cardiac death

7. CLINICAL SUBTYPES

Type A

Peripartum Cardiomyopathy-Associated Heart Failure

Most common severe subtype.

Type B

Hypertensive Postpartum Heart Failure

Associated with:

Preeclampsia
Eclampsia
Chronic hypertension

Type C

Diastolic Heart Failure (HFpEF)

Preserved ejection fraction with impaired ventricular relaxation.

Type D

Systolic Heart Failure (HFrEF)

Reduced ventricular ejection fraction.

Type E

Acute Pulmonary Edema Syndrome

Rapid postpartum fluid overload.

Type F

Cardiogenic Shock Syndrome

Severe terminal cardiovascular collapse.

8. DIAGNOSTIC BIOMARKERS

Cardiac Biomarkers

Elevated:

BNP
NT-proBNP
Troponin I
Troponin T

Inflammatory Biomarkers

Potential elevations:

CRP
IL-6
TNF-α

Imaging

Echocardiography

Evaluates:

Ejection fraction
Ventricular dimensions
Diastolic function

Cardiac MRI

Assesses:

Myocardial inflammation
Fibrosis
Remodeling

Chest Imaging

Identifies:

Pulmonary edema
Pleural effusions
Cardiomegaly

9. SCF THERAPEUTIC MECHANISMS

A. SCF-PCR PREVENTATIVE MODULE

Objectives

Prevent cardiac decompensation in high-risk postpartum patients.

Targets:

Endothelial dysfunction
Hypertension
Oxidative stress
Volume overload

B. SCF-PCR CURATIVE MODULE

Objectives

Restore adequate cardiac function.

Therapeutic targets:

Ventricular contractility
Neurohormonal dysregulation
Pulmonary congestion
Myocardial inflammation

Clinical interventions:

Guideline-directed heart failure therapy
Diuresis
Hemodynamic stabilization
Anti-remodeling strategies

C. SCF-PCR RESTORATIVE MODULE

Objectives

Promote long-term cardiovascular recovery.

Targets:

Mitochondrial recovery
ECM normalization
Neurohormonal recalibration
Functional cardiac rehabilitation

10. RESISTANCE & OFF-TARGET MODELING

Failure Node	Consequence
Persistent ventricular dysfunction	Chronic heart failure
Progressive fibrosis	Reduced recovery
Chronic inflammation	Ongoing remodeling
Neurohormonal activation	Recurrent decompensation
Mitochondrial dysfunction	Persistent exercise intolerance
Renal impairment	Cardiorenal syndrome

11. PROGNOSTIC STRATIFICATION

Low Risk

Rapid symptom resolution
Preserved ventricular function
Minimal remodeling

Intermediate Risk

Persistent ventricular dysfunction
Recurrent admissions
Moderate remodeling

High Risk

LVEF <25%
Cardiogenic shock
Severe pulmonary edema
Mechanical circulatory support requirement

12. SCF THERAPEUTIC TARGET MAP

Target	SCF Function
RAAS	Neurohormonal stabilization
Sympathetic pathways	Cardiac workload reduction
VEGF	Vascular repair
TNF-α	Inflammation control
IL-6	Immune regulation
STAT3	Mitochondrial protection
AMPK	Bioenergetic restoration
PI3K/AKT	Cell survival
ECM pathways	Structural remodeling control
Mitochondria	Energy recovery

13. PROJECT RHENOVA INTEGRATION PATHWAYS

RHENOVA-CARDIO-PPHF

Research Module A

Maternal cardiovascular collapse mapping.

Research Module B

Postpartum neurohormonal dysregulation atlas.

Research Module C

Cardio-immunometabolic failure network analysis.

Research Module D

Mitochondrial dysfunction and recovery platform.

Research Module E

Precision postpartum heart failure therapeutic engineering.

14. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Maternal heart failure multi-omic atlas development.

Priority 2

Postpartum cardio-immunometabolic biomarker panels.

Priority 3

Mitochondrial restoration therapeutics.

Priority 4

AI-guided decompensation prediction systems.

Priority 5

SCF-derived regenerative cardiovascular API discovery programs.

SCF-RDOS INDICATION SUMMARY

Parameter	Classification
Disease	Postpartum Heart Failure
Registry Code	SCF-RDOS-PPD-CV-002
Disease Domain	Cardiovascular
SCF Fault Tier	IV–VII
Primary Systems	Cardiovascular, Endocrine, Immune, Metabolic
Principal Fault Nodes	ATP Collapse, Neurohormonal Hyperactivation, Endothelial Dysfunction
Mortality Risk	High
Therapeutic Priority	Critical
SCF-PCR Applicability	Preventative, Curative, Restorative

MASTER REGISTRY INDEX

SCF-RDOS-PPD-CV-002 — Postpartum Heart Failure

SCF-RDOS-PPD-CV-001 — Peripartum Cardiomyopathy

SCF-PATH-0001 — SCF Pathophysiology Protocol (Universal Template)

SCF-SEF-MD-0001 — SCF Synergistic Evaluation Framework

SCF-CRD-WORKFLOW-0001 — SCF Clinical Research & Development Workflow

SCF-API-DP-0001 — SCF API Discovery Profile

SCF-RDOS-PPD-0001 — Postpartum Disorders & Diseases Registry

SCF-ENC-IND-CV-0002 — SCF Encyclopedia Entry Series: Postpartum Cardiovascular Disorders